Dongxue Sun

Daiwa Securities Co., Ltd. engages in the business of financial instruments trading services which includes underwriting securities and its related business. It also provides the online trading, brokerage, purchase and sale of securities and acts as an agent or perform agency functions. The company was founded in 1943 and is headquartered in Tokyo, Japan.

Part of Daiwa Securities Group, Inc., Daiwa Fund Consulting Co. Ltd. is a Japanese company that provides asset management, discretionary investment, and investment advisory services. The company is based in Chiyoda-ku, Japan. The company was founded in 2006. The CEO is Tetsuo Akuzawa.

SPinno Co., Ltd. provides cloud platform, promotional marketing and digital marketing services. The company was founded in April 2009 and is headquartered in Tokyo, Japan.

Hotung Venture Capital Corp invests in companies located in Greater China, primarily in Taiwan, China and the US. The fund focuses on companies operating in the fields of IC design & semiconductors, optoelectronics, electronic components, wireless communications, new materials, software, internet, IT services, retail, e-business, and biochemistry. It provides financing for early, expansion and later stage capital requirements. It invests in both public and private companies.

Part of Daiwa Securities Group, Inc., Daiwa Corporate Investment Asia Ltd. is a Chinese company that provides securities brokerage, investment banking, and asset management services. The company is based in Hong Kong, Hong Kong.

Global X Japan Co., Ltd. is a joint venture between Daiwa Securities Group Inc., Daiwa Asset Management Co. Ltd., and X Management Company, Inc. The joint venture company was founded in 2019 and is based in Chiyoda-ku, Japan. Global X Japan Co. is the Japanese only ETF specialist asset management company in Japan, offering innovative ETF lineups such as growth themes, income types, and core types (ESG-related, etc .). The company provides research and reports to its clients.

REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan.

Daiwa PI Partners Co. Ltd. is a Private Equity firm, a subsidiary of Daiwa Investment Management, itself a subsidiary of Daiwa Securities Group Inc. (TYO:8601), founded in 1998. Daiwa PI Partners Co. Ltd. is headquartered in Tokyo, Japan with additional office in Myanmar.

Huitung Investments (BVI) Ltd invests in companies located in Greater China, primarily in Taiwan, China and the US. The fund focuses on companies operating in the fields of IC design & semiconductors, optoelectronics, electronic components, wireless communications, new materials, software, internet, IT services and biochemistry. It provides financing for early, expansion and later stage capital requirements. It invests both in public and private companies.

TMRC Co. Ltd. provides contract research and manufactures medicines. It develops anti-cancer products and those for cancer associated disorders. The company was founded by Hisao Ekimoto in January 2002 and is headquartered in Tokyo, Japan.

DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan.